Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Continues To Speed PD-1/L1 Drugs To Market

Oct 25 2016

• By Mary Jo Laffler and Bridget Silverman

Related Content

FDA ‘Expedited Review’ Would Shave Off Additional Month For Some ‘Breakthrough’ Products

Mar 10 2015

Will The New Math Of Oncology Drug Review Times Carry Over Into PDUFA V?

Nov 01 2012

'Total Disaster' In First-Line Lung Cancer For BMS's Opdivo

Oct 10 2016

It’s Here: Merck’s Keytruda Cleared For First-Line Lung Cancer

Oct 25 2016

Related Companies

Merck & Co., Inc.

Bristol Myers Squibb Company

Roche Holding AG

Additional Topics

United States Approvals Regulation Drug Review Cancer BioPharmaceutical

More from Approvals

More from Product Reviews

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window